Astrotech Corporation — Form 10-Q Summary
Period note: The filing covers the quarter and six months ended December 31, 2021 (fiscal 2022 second quarter). This differs from the “2020 Q2” period in the request metadata.
Business context
Astrotech commercializes mass spectrometry technology through wholly owned subsidiaries focused on security detection (1st Detect), agriculture (AgLAB), and breath analysis (BreathTech). The reported revenue came from TRACER 1000 sales; the company reported no segment information.
Financial performance
Amounts below are in millions of dollars, except per-share data and percentages.
| Metric | Three months ended Dec. 31, 2021 | Three months ended Dec. 31, 2020 | Six months ended Dec. 31, 2021 | Six months ended Dec. 31, 2020 |
|---|---|---|---|---|
| Revenue | $0.561 | $0.130 | $0.748 | $0.270 |
| Gross profit / margin | $0.120 / 21% | $0.002 / 2% | $0.132 / 18% | $0.029 / 11% |
| Operating expenses | $2.380 | $1.561 | $4.445 | $3.640 |
| Operating loss | $(2.260) | $(1.559) | $(4.313) | $(3.611) |
| Net loss | $(2.180) | $(1.622) | $(4.209) | $(3.733) |
| Net loss per share | $(0.05) | $(0.10) | $(0.09) | $(0.32) |
For the six months ended December 31, 2021, operating cash use was $3.484 million, investing cash use was $0.264 million, and financing cash use was $2.018 million. Cash and cash equivalents declined $5.766 million to $30.170 million. At period-end, short-term investments were $27.106 million, working capital was approximately $56.9 million, and total assets were $60.385 million.
Total liabilities were $2.834 million, including a $0.500 million related-party note payable and $0.648 million of lease liabilities. Stockholders’ equity was $57.551 million.
Changes and management commentary
- Quarterly revenue increased $0.431 million year over year; six-month revenue increased $0.478 million. The company attributed the increase to TRACER 1000 sales to DHL and an airport checkpoint customer. Two customers comprised all revenue in the quarter and six-month period.
- Gross margin improved year over year, which management attributed to higher production volumes, volume discounts, and product enhancements.
- Quarterly SG&A increased $0.925 million, largely due to non-cash equity compensation, payroll accruals, and derivative-litigation legal costs. R&D spending declined as the company shifted emphasis toward commercialization.
- The company repaid $2.0 million of related-party note principal and paid accrued interest in September 2021; $0.5 million remained due September 5, 2022. The prior-year period included $21.8 million of net stock-offering proceeds.
Outlook, risks, and contingencies
- Management said it expected liquidity to meet cash-flow needs during fiscal 2022 and the immediate future; it gave no quantified revenue or earnings guidance. It may consider strategic transactions or additional financing, but cannot assure favorable financing terms or availability.
- TSA cargo detection testing remained ongoing and slower than anticipated due to COVID-19-related delays. Completion is required for the TRACER 1000 to be listed as approved for U.S. air-cargo sales. The company reported deliveries of its first airport-checkpoint order during the quarter.
- Management cited semiconductor and electronics shortages, input and shipping cost inflation, uncertain airline-sector recovery, and pandemic-related disruption. It said it was seeking alternative supplies and expected to pass cost increases to customers through higher instrument prices, while warning prolonged shortages could harm results.
- Nasdaq notified the company on December 21, 2021 that its share price had failed the $1.00 minimum bid requirement. It had until June 20, 2022 to regain compliance, with possible additional time subject to eligibility; otherwise, delisting could be a risk.
- A Delaware stockholder class and derivative action remained subject to anticipated settlement approval in the first half of 2022. The court had validated the challenged certificate amendment in October 2021.
- The company recorded no income tax benefit and maintained a full valuation allowance against deferred tax assets. It reported approximately $0.3 million of uncertain tax positions.
Important facts for investors to verify
- Whether TSA cargo detection testing is completed and the TRACER 1000 receives U.S. approval, and whether checkpoint and other customer orders expand.
- Revenue concentration, repeat sales, gross-margin durability, and the company’s path to reducing operating losses and cash use.
- Cash and investment levels relative to ongoing operating needs, planned spending, lease obligations, and the September 2022 related-party note maturity.
- Progress toward Nasdaq bid-price compliance and the potential effects of any compliance measures.
- Outcome and potential costs of the Delaware litigation settlement, along with supply-chain constraints and cost pass-through to customers.